KARMOXY

Serial Number 87778498
602

Registration Progress

Application Filed
Jan 31, 2018
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

KARMOXY

Basic Information

Serial Number
87778498
Filing Date
January 31, 2018
Abandonment Date
February 1, 2021
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Feb 16, 2021
Classes
005

Rights Holder

AstraZeneca AB

99
Address
Vastra Malarehamnen 9
Södertälje SE-15185
SE

Ownership History

AstraZeneca AB

Original Applicant
99
Södertälje SE

Legal Representation

Attorney
Wm. Charles Saunders

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

31 events
Date Code Type Description Documents
Feb 17, 2021 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Feb 16, 2021 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Jul 29, 2020 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Jul 29, 2020 GNSI S INQUIRY TO SUSPENSION E-MAILED Loading...
Jul 29, 2020 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Loading...
Jun 30, 2020 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Dec 30, 2019 CNSL R SUSPENSION LETTER WRITTEN Loading...
Dec 30, 2019 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Dec 30, 2019 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Dec 21, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 21, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 17, 2019 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Aug 8, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 8, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 8, 2019 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Jul 8, 2019 GNSI S INQUIRY TO SUSPENSION E-MAILED Loading...
Jul 8, 2019 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Loading...
Jun 13, 2019 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Jun 3, 2019 ALIE A ASSIGNED TO LIE Loading...
Oct 29, 2018 CNSL R SUSPENSION LETTER WRITTEN Loading...
Oct 29, 2018 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Oct 29, 2018 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Oct 19, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 18, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 18, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 17, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 17, 2018 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 17, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 14, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 10, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 3, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005